Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies
Lianlian Bian, Fan Gao, Jialu Zhang, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 4, pp. 365-373
Open Access | Times Cited: 168

Showing 1-25 of 168 citing articles:

A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 118
To mix or not to mix? A rapid systematic review of heterologous prime–boost covid-19 vaccination
Nan-Chang Chiu, Hsin Chi, Yu‐Kang Tu, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 10, pp. 1211-1220
Open Access | Times Cited: 110
SARS‐CoV‐2 variants and vulnerability at the global level
Vivek P. Chavda, Aayushi Patel, Darsh D. Vaghasiya
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 2986-3005
Open Access | Times Cited: 108
Nanotechnology-based strategies against SARS-CoV-2 variants
Xiangang Huang, Edo Kon, Xuexiang Han, et al.
Nature Nanotechnology (2022) Vol. 17, Iss. 10, pp. 1027-1037
Open Access | Times Cited: 102
Targeting SARS-CoV-2 Main Protease for Treatment of COVID-19: Covalent Inhibitors Structure–Activity Relationship Insights and Evolution Perspectives
Gabriele La Monica, Alessia Bono, Antonino Lauria, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 19, pp. 12500-12534
Open Access | Times Cited: 99
Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions
Ahmed I. Abulsoud, Hussein M. El‐Husseiny, Ahmed A. El-Husseiny, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113977-113977
Open Access | Times Cited: 88
mRNA Covid-19 vaccines in pregnancy: A systematic review
Nando Reza Pratama, Ifan Ali Wafa, David Setyo Budi, et al.
PLoS ONE (2022) Vol. 17, Iss. 2, pp. e0261350-e0261350
Open Access | Times Cited: 86
SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic
Chiranjib Chakraborty, Manojit Bhattacharya, Kuldeep Dhama
Vaccines (2023) Vol. 11, Iss. 3, pp. 682-682
Open Access | Times Cited: 59
The real-life impact of vaccination on COVID-19 mortality in Europe and Israel
Katarzyna Jabłońska, Samuel Aballéa, Mondher Toumi
Public Health (2021) Vol. 198, pp. 230-237
Open Access | Times Cited: 94
Potency of BNT162b2 and mRNA‐1273 vaccine‐induced neutralizing antibodies against severe acute respiratory syndrome‐CoV‐2 variants of concern: A systematic review of in vitro studies
Maryam Noori, Seyed Aria Nejadghaderi, Shahnam Arshi, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 73
Plant-Based COVID-19 Vaccines: Current Status, Design, and Development Strategies of Candidate Vaccines
Puna Maya Maharjan, Sunghwa Choe
Vaccines (2021) Vol. 9, Iss. 9, pp. 992-992
Open Access | Times Cited: 67
New variants of SARS-CoV-2
Rafael Cantón, Pilar Ramos, Alejandra García‐Botella, et al.
Revista Española de Quimioterapia (2021) Vol. 34, Iss. 5, pp. 419-428
Open Access | Times Cited: 63
Controversy surrounding the Sputnik V vaccine
Mario Cazzola, Paola Rogliani, Filomena Mazzeo, et al.
Respiratory Medicine (2021) Vol. 187, pp. 106569-106569
Open Access | Times Cited: 60
SARS-CoV-2 Variants and Clinical Outcomes: A Systematic Review
Indira R. Mendiola‐Pastrana, Eduardo López‐Ortiz, José G. Río de la Loza-Zamora, et al.
Life (2022) Vol. 12, Iss. 2, pp. 170-170
Open Access | Times Cited: 60
Delta Variant: The New Challenge of COVID-19 Pandemic, an Overview of Epidemiological, Clinical, and Immune Characteristics.
Noosha Samieefar, Ronak Rashedi, Meisam Akhlaghdoust, et al.
PubMed (2022) Vol. 93, Iss. 1, pp. e2022179-e2022179
Closed Access | Times Cited: 47
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
Risk assessment of COVID-19 epidemic resurgence in relation to SARS-CoV-2 variants and vaccination passes
Tyll Krueger, Krzysztof Gogolewski, Marcin Bodych, et al.
Communications Medicine (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 45
The Promising Potential of Reverse Vaccinology-Based Next-Generation Vaccine Development over Conventional Vaccines against Antibiotic-Resistant Bacteria
Kanwal Khalid, Chit Laa Poh
Vaccines (2023) Vol. 11, Iss. 7, pp. 1264-1264
Open Access | Times Cited: 33
Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants
Divya Teli, Pankti C. Balar, Kishan Patel, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 309-309
Open Access | Times Cited: 25
Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection
Richard A. Urbanowicz, Theocharis Tsoleridis, Hannah Jackson, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 609
Open Access | Times Cited: 47
Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine
Koichi Furukawa, Lidya Handayani Tjan, Yukiya Kurahashi, et al.
JAMA Network Open (2022) Vol. 5, Iss. 5, pp. e2210780-e2210780
Open Access | Times Cited: 34
Real-Word Effectiveness of Global COVID-19 Vaccines Against SARS-CoV-2 Variants: A Systematic Review and Meta-Analysis
Kai Wang, Lin Wang, Mingzhe Li, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 33
Mix-and-Match COVID-19 Vaccinations (Heterologous Boost): A Review
Ishan Garg, Abu Baker Sheikh, Suman Pal, et al.
Infectious Disease Reports (2022) Vol. 14, Iss. 4, pp. 537-546
Open Access | Times Cited: 30
The anti–SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination
Robert J. Benschop, Jay Tuttle, Lin Zhang, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 655
Open Access | Times Cited: 29
A multiplex protein panel assay for severity prediction and outcome prognosis in patients with COVID-19: An observational multi-cohort study
Ziyue Wang, Adam Cryar, Oliver Lemke, et al.
EClinicalMedicine (2022) Vol. 49, pp. 101495-101495
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top